Business description: Bayer AG

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:

- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;

- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;

- OTC products and nutritional supplements (12.7%);

- other (0.5%).

Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Number of employees: 94,245

Sales by Activity: Bayer AG

Fiscal Period: December20192020202120222023

Crop Science

19.85B 18.85B 20.22B 25.18B 23.29B

Pharmaceuticals

17.99B 17.29B 18.37B 19.26B 18.11B

Consumer Health

5.47B 5.05B 5.29B 6.08B 6.03B

All Other

2.65B 372M 203M 219M 239M

Enabling Functions and Consolidation

-2.42B -163M -5M -1M -36M
See all business segments

Geographical breakdown of sales: Bayer AG

Fiscal Period: December20192020202120222023

United States

13.56B 12.88B 13.4B 15.68B 14.59B

Europe / Middle East / Africa (Excl. Germany & Switzerland)

10.32B 10.02B 10.56B 11.35B 11.07B

Brazil

3.54B 2.99B 3.48B 5.32B 4.97B

Asia / Pacific (Excl.China)

4.88B 4.78B 4.99B 5.19B 4.74B

Latin America (Excl. Brazil)

3.12B 2.91B 3.16B 3.97B 3.96B

China

3.73B 3.48B 3.86B 4.26B 3.62B

Germany

2.36B 2.36B 2.54B 2.48B 2.45B

North America (Excl.United States)

1.53B 1.47B 1.56B 1.89B 1.67B

Switzerland

505M 496M 542M 600M 567M
See all geographic segments

Managers: Bayer AG

Director TitleAgeSince
Chief Executive Officer 58 2023-05-31
Director of Finance/CFO 55 2018-05-31
Chief Tech/Sci/R&D Officer 57 2021-01-31
Chief Tech/Sci/R&D Officer 55 2020-05-31
Investor Relations Contact - 2021-10-31
See BAYER AG governance

Members of the board: Bayer AG

Manager TitleAgeSince
Director/Board Member 68 2002-03-31
Director/Board Member 54 2012-03-31
Director/Board Member 65 2022-03-31
Director/Board Member 63 2015-10-31
Director/Board Member 69 2017-03-31
Director/Board Member 59 2017-03-31
Chairman 67 2020-04-27
Director/Board Member 67 2019-09-30
Director/Board Member 67 2020-04-27
Director/Board Member 68 2021-03-31
Composition of the Board of Directors

Shareholders: Bayer AG

NameEquities%Valuation
Norges Bank Investment Management
3.147 %
30,920,064 3.147 % 832 M €
Silchester International Investors LLP
3.002 %
29,496,952 3.002 % 794 M €
Temasek Holdings Pte Ltd. (Investment Management)
3.000 %
29,472,722 3.000 % 793 M €
Amundi Asset Management SA (Investment Management)
1.695 %
16,647,666 1.695 % 448 M €
State Street Global Advisors Ltd.
0.2288 %
2,247,768 0.2288 % 61 M €
NameEquities%Valuation
Kahn Brothers Group, Inc.
0.1313 %
5,159,540 0.1313 % 35 M €
Mcginn Penninger Investment Management, Inc.
0.0224 %
881,139 0.0224 % 6 M €
Goldman Sachs Asset Management International
0.004002 %
157,269 0.004002 % 1 M €
Great Lakes Advisors LLC
0.001849 %
72,670 0.001849 % 489 069 €
Yousif Capital Management LLC
0.001543 %
60,640 0.001543 % 408 107 €
List of BAYER AG shareholders

Holdings: Bayer AG

NameEquities%Valuation
32,102,99971.43%2,531,206,542 $
12,675,83814.96%14,577,214 $
2,742,3384.61%9,762,723 $
4,050,99710.82%7,980,464 $
1,615,2017.26%4,716,387 $
587,84912.84%1,275,632 $
1,490,6250.38%391,021 $
48,3240.63%24,065 $

Company details: Bayer AG

Bayer AG

Kaiser-Wilhelm-Allee 1

51368, Leverkusen

+49 214 30 1

http://www.bayer.com
address Bayer AG(BAYN)

Group companies: Bayer AG

NameCategory and Sector
Chemicals: Agricultural
Bayer HealthCare Ltd.
Pharmaceuticals: Major
Pharmaceuticals: Major
Chemicals: Agricultural
See all subsidiaries

Other Pharmaceuticals

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.01%+0.38%-37.62%-56.87%19.86B
+1.69%+3.04%+39.26%+231.19%732B
-0.45%+4.80%+12.55%+119.90%488B
-1.58%-1.40%-3.80%-4.40%367B
-0.15%+0.20%+26.56%+52.71%321B
+1.23%+0.23%-1.56%+38.87%258B
-0.12%+0.55%+3.09%-30.92%231B
-1.89%-1.61%+5.94%+22.28%210B
-2.64%-0.19%+2.40%+25.70%212B
+0.08%-0.60%+2.15%+37.48%150B
Average -0.38%+0.68%+4.90%+43.59% 298.69B
Weighted average by Cap. -0.31%+1.24%+14.61%+87.23%
See all sector performances
Trading Rating
Investor Rating
ESG Refinitiv
B-
surperformance-ratings-light-chart BAYER-AGMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
19.23EUR
Average target price
28.16EUR
Spread / Average Target
+46.38%
Consensus

Quarterly revenue - Rate of surprise

Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW